Literature DB >> 33863864

Myalgia as a symptom at hospital admission by severe acute respiratory syndrome coronavirus 2 infection is associated with persistent musculoskeletal pain as long-term post-COVID sequelae: a case-control study.

César Fernández-de-Las-Peñas1, Jorge Rodríguez-Jiménez, Stella Fuensalida-Novo, María Palacios-Ceña, Víctor Gómez-Mayordomo, Lidiane L Florencio, Valentín Hernández-Barrera, Lars Arendt-Nielsen.   

Abstract

ABSTRACT: This study investigated the association between COVID-related myalgia experienced by patients at hospital admission and the presence of post-COVID symptoms. A case-control study including patients hospitalised due to COVID-19 between February 20 and May 31, 2020, was conducted. Patients reporting myalgia and patients without myalgia at hospital admission were scheduled for a telephone interview 7 months after hospital discharge. Hospitalisation and clinical data were collected from medical records. A list of post-COVID symptoms with attention to musculoskeletal pain was evaluated. Anxiety and depressive symptoms, and sleep quality were likewise assessed. From a total of 1200 hospitalised patients with COVID-19, 369 with and 369 without myalgia at hospital admission were assessed 7.2 months (SD 0.6) after hospital discharge. A greater proportion (P = 0.03) of patients with myalgia at hospital admission (20%) showed ≥3 post-COVID symptoms when compared with individuals without myalgia (13%). A higher proportion of patients presenting myalgia (odds Rratio 1.41, 95% confidence interval 1.04-1.90) exhibited musculoskeletal post-COVID pain when compared to those without myalgia. The prevalence of musculoskeletal post-COVID pain in the total sample was 38%. Fifty percent of individuals with preexisting musculoskeletal pain experienced a worsening of their symptoms after COVID-19. No differences in fatigue, dyspnoea, anxiety/depressive levels, or sleep quality were observed between myalgia and nonmyalgia groups. The presence of myalgia at hospital admission was associated with preexisting history of musculoskeletal pain (OR 1.62, 95% confidence interval 1.10-2.40). In conclusion, myalgia at the acute phase was associated with musculoskeletal pain as long-term post-COVID sequelae. In addition, half of the patients with preexisting pain conditions experienced a persistent exacerbation of their previous syndromes.
Copyright © 2021 International Association for the Study of Pain.

Entities:  

Year:  2021        PMID: 33863864     DOI: 10.1097/j.pain.0000000000002306

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  15 in total

1.  [Guideline S1: Long COVID: Diagnostics and treatment strategies].

Authors:  Susanne Rabady; Johann Altenberger; Markus Brose; Doris-Maria Denk-Linnert; Elisabeth Fertl; Florian Götzinger; Maria de la Cruz Gomez Pellin; Benedikt Hofbaur; Kathryn Hoffmann; Renate Hoffmann-Dorninger; Rembert Koczulla; Oliver Lammel; Bernd Lamprecht; Judith Löffler-Ragg; Christian A Müller; Stefanie Poggenburg; Hans Rittmannsberger; Paul Sator; Volker Strenger; Karin Vonbank; Johannes Wancata; Thomas Weber; Jörg Weber; Günter Weiss; Maria Wendler; Ralf-Harun Zwick
Journal:  Wien Klin Wochenschr       Date:  2021-12-01       Impact factor: 1.704

Review 2.  COVID-19 2022 update: transition of the pandemic to the endemic phase.

Authors:  Michela Biancolella; Vito Luigi Colona; Giuseppe Novelli; Juergen K V Reichardt; Ruty Mehrian-Shai; Jessica Lee Watt; Lucio Luzzatto
Journal:  Hum Genomics       Date:  2022-06-01       Impact factor: 6.481

3.  Trigger point injections and dry needling can be effective in treating long COVID syndrome-related myalgia: a case report.

Authors:  Mengyi Zha; Kristina Chaffee; Jude Alsarraj
Journal:  J Med Case Rep       Date:  2022-01-17

Review 4.  Post-Acute COVID-19 Syndrome for Anesthesiologists: A Narrative Review and a Pragmatic Approach to Clinical Care.

Authors:  Rafal Kopanczyk; Nicolas Kumar; Thomas Papadimos
Journal:  J Cardiothorac Vasc Anesth       Date:  2021-10-03       Impact factor: 2.894

Review 5.  A Review: The Manifestations, Mechanisms, and Treatments of Musculoskeletal Pain in Patients With COVID-19.

Authors:  Lijuan Wang; Na Yang; Jinfeng Yang; Shuwu Zhao; Chen Su
Journal:  Front Pain Res (Lausanne)       Date:  2022-03-10

Review 6.  The Short- and Long-Term Clinical, Radiological and Functional Consequences of COVID-19.

Authors:  Yang Gao; Wei-Quan Liang; Yi-Ran Li; Jian-Xing He; Wei-Jie Guan
Journal:  Arch Bronconeumol       Date:  2022-04-13       Impact factor: 6.333

Review 7.  Clinical Characteristics and Mechanisms of Musculoskeletal Pain in Long COVID.

Authors:  Omar Khoja; Bárbara Silva Passadouro; Matthew Mulvey; Ioannis Delis; Sarah Astill; Ai Lyn Tan; Manoj Sivan
Journal:  J Pain Res       Date:  2022-06-17       Impact factor: 2.832

8.  Post-COVID pain and quality of life in COVID-19 patients: protocol for a meta-analysis and systematic review.

Authors:  Mengrong Miao; Yongxing Xu; Yitian Yang; Pule Li; Mengqi Jia; Zhaoyu Wen; Mengmeng Yu; Jiaqiang Zhang; Jianwen Gu
Journal:  BMJ Open       Date:  2022-07-18       Impact factor: 3.006

Review 9.  The COVID-19 pandemic and its consequences for chronic pain: a narrative review.

Authors:  H Shanthanna; A M Nelson; N Kissoon; S Narouze
Journal:  Anaesthesia       Date:  2022-07-18       Impact factor: 12.893

Review 10.  COVID-19 in Joint Ageing and Osteoarthritis: Current Status and Perspectives.

Authors:  Marianne Lauwers; Manting Au; Shuofeng Yuan; Chunyi Wen
Journal:  Int J Mol Sci       Date:  2022-01-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.